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Abstract
Methoxyestradiol (2-ME), an endogenous metabolite of estradiol, not only exerts cytotoxic effects on
cancer cells but also protects against multiple proliferative disorders, including atherosclerosis and
injury-induced intimal thickening. However, the molecular mechanisms by which 2-ME induces its
anti-vasoocclusive actions are largely unknown. Given that abnormal growth and excessive proliferation
of smooth muscle cells (SMCs) importantly contribute to the vascular remodeling process associated
with hypertension and atherosclerosis, the aims of this study were to assess the impact of 2-ME on
pathophysiological pathways regulating SMC growth using transcriptional profiling. High-density
oligonucleotide microarrays (Affymetrix Human Genome U_133 Plus 2.0 GeneChips) were used to
identify differentially expressed genes in cultured human aortic SMCs treated with 2-ME (acutely, for 4
hrs, n=3; and chronically, for 48 hrs, n=3) and vehicle-treated time-matched controls (n=3 for each time
point). Both single gene analysis (performed using Significance Analysis of Microarrays) as well as
Gene Set Enrichment Analysis (GSEA, a computational method that determines whether an a priori
defined set of genes shows statistically significant, concordant differences between two biological
states) indicated downregulation of genes critically involved in mitotic spindle assembly and function in
SMCs chronically treated with 2-ME when compared to control cultures. GSEA analysis identified
significant effects of 2-ME on cell cycle progression, cell migration/adhesion, vasorelaxation, apoptosis,
the inflammatory response, and cholesterol homeostasis/metabolism. Major changes were also observed
in genes regulating the respiratory chain and redox pathways. Identification of candidate genes that are
positively or negatively regulated by 2-ME provides important leads to investigate and better understand
the mechanisms by which 2-ME induces its vasoprotective and antivasoocclusive actions. 
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Abstract: 
 
Methoxyestradiol (2-ME), an endogenous metabolite of estradiol, not only exerts cytotoxic 
effects on cancer cells but also protects against multiple proliferative disorders, including 
atherosclerosis and injury-induced intimal thickening. However, the molecular mechanisms 
by which 2-ME induces its anti-vasoocclusive actions are largely unknown. Given that 
abnormal growth and excessive proliferation of smooth muscle cells (SMCs) importantly 
contribute to the vascular remodeling process associated with hypertension and 
atherosclerosis, the aims of this study were to assess the impact of 2-ME on 
pathophysiological pathways regulating SMC growth using transcriptional profiling. High-
density oligonucleotide microarrays (Affymetrix Human Genome U_133 Plus 2.0 GeneChips) 
were used to identify differentially expressed genes in cultured human aortic SMCs treated 
with 2-ME (acutely, for 4 hrs, n=3; and chronically, for 48 hrs, n=3) and vehicle-treated time-
matched controls (n=3 for each time point). Both single gene analysis (performed using 
Significance Analysis of Microarrays) as well as Gene Set Enrichment Analysis (GSEA, a 
computational method that determines whether an a priori defined set of genes shows 
statistically significant, concordant differences between two biological states) indicated 
downregulation of genes critically involved in mitotic spindle assembly and function in SMCs 
chronically treated with 2-ME when compared to control cultures. GSEA analysis identified 
significant effects of 2-ME on cell cycle progression, cell migration/adhesion, vasorelaxation, 
apoptosis, the inflammatory response, and cholesterol homeostasis/metabolism. Major 
changes were also observed in genes regulating the respiratory chain and redox pathways. 
Identification of candidate genes that are positively or negatively regulated by 2-ME provides 
important leads to investigate and better understand the mechanisms by which 2-ME induces 
its vasoprotective and antivasoocclusive actions. 
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